Related Experiment Video
Updated: Sep 19, 2025

An In Vitro Model of a Parallel-Plate Perfusion System to Study Bacterial Adherence to Graft Tissues
Published on: January 7, 2019
Enterococcus durans endocarditis with prosthetic valve and implantable electronic device and literature review
1Department of Infectious Diseases and Clinical Microbiology, Ministry of Health Sivas Numune Hospital, Sivas, Türkiye.
Abstract:
Enterococcus durans is an extremely rare cause of infectious endocarditis. To date, only nine cases of endocarditis or cardiac implantable electronic device (CIED) infection due to E. durans have been reported in the literature. A 48-year-old man with hypertension, non-ischemic dilated cardiomyopathy, previous aortic valve replacement and cardiac resynchronisation implantation with defibrillator presented with weakness, anorexia, nausea, vomiting and weight loss for 7 months. Transthoracic echocardiography showed a 10 mm mobile vegetation on the aortic valve. Ampicillin and gentamicin-sensitive Enterococcus durans was grown in 3 sets of blood-cultures within 24-72 hours of admission. The patient who developed septic embolism complication was successfully treated with gentamicin and ampicillin for 6 weeks. Enterococcus durans is an extremely rare cause of infectious endocarditis whose risk factors, natural history and response to treatment remain unclear. This rare and potentially high mortality infectious agent should be kept in mind in patients with bioprosthetic-valves and CIED.
More Related Videos
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Mitral Stenosis III: Medical Management

